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Communication

precursor for three second messengers: inositol 1,4,5-trisphosphate (1)and diacylglycerol (2), both produced by phosphoinositide-specificphospholipases C (31, and phosphatidylinositol3,4,5-trisphosphate, generated by a phosphoinositide 3-kinase (4). The mobilization of these signaling pathways by cell
surface receptors is often accompanied by activation of phospholipase D (PLD). PLD activation has been implicated in a
novel signal transduction pathway employed bya wide variety
of extracellular signal molecules in eukaryotic cells (5, 6). The
(Received for publication, July 5, 1994)
activation of PLD is regulated by G protein(s) and protein kiMordechai LiscovitchM, Vered ChalifaS,
nase(s). Recent results have implicatedPLD activation also in
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intracellular membrane traffic (7, 8). However, there is little
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information on the biochemical and molecular properties of
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signal-activated PLDs, and, to date, none of the mammalian
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PLDs has been isolated or cloned (reviewed in Ref. 6).
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noglycosides inhibit brain membrane PLD activity, as well as
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rived NG108-15 cells (9). Because neomycin binds with high
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afflnity to negatively charged phospholipids suchas phosphoinositides,
we suggested that acidic phospholipids may act as
The activation of phospholipaseD (PLD)is a receptoressential cofactors for PLD activity (9). The evidence provided
mediated event that has been implicated in signal transduction and membrane traffic
in eukaryotic cells. Little herein indicates that PIP, functions as such a cofactor.
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is known about the biochemical and molecular properEXPERIMENTALPROCEDURES
ties of signal-activated PLDs, and none has been
isoMaterials-Phosphatidylinositol
4,5-bisphosphate was obtained
lated. Herewereportthatphosphatidylinositol4,5Corp.
and Sigma.
l-Palmitoyl-2-16-N-(7from U. S. Biochemical
bisphosphate(PIP,)potentlystimulatesbrainmembrane PLD activity in vitro in a highly specific manner. nitrobenzo-2-oxa-l,3-diazol-4-yl)amino]caproyl-phosphatidylcholine
(C,-NBD-PC) was from Avanti Polar Lipids. The chemical synthesis of
PIP, increases 10-fold the maximal activity of a partially
dipalmitoylphosphatidylinositol3,4,5-trisphosphate
will bedescribed in
purified PLD with an EC, of c0.5 mol %. Other acidic detail elsewhere. Other phospholipids, sodium oleate, and neomycin
phospholipids,includingphosphatidylinositol4-phoswere from Sigma.
phate,phosphatidylinositol,phosphatidylserine,and
Purification and Assay of Rat Brain Membrane PLD-Rat brain
phosphatidic acid, are completely or nearly ineffective.membranes were prepared and treated with a high salt concentration
Neomycin, a high affinity ligand
of PIP,, inhibits mem- (to remove peripheral membrane proteins) according to Danin et ai.
brane-bound PLD but has no effect on the activity
of a (10). These membranes were then utilized in measurements of memdetergent-solubilizedor partially purified enzyme. The brane-bound PLD activity and for solubilization and purification of
of partially pu- PLD. PLD activity was solubilized as described previously (lo), except
addition of PIP, restores the sensitivity
w/v) was utilized as the solubilizing detergent.
rified PLD to neomycin inhibition, indicating that neo- that Triton X-100 (l%,
The solubilized PLD activity was further purified by chromatography
mycin blocks membrane PLDactivity by binding toenon Q-Sepharose, reactive dye-agarose, and hydroxylapatite columns.
dogenous PIP,. These results define a novel function ofDetails of the purification procedure will be published elsewhere. The
PIP, as a cofactor for brain membrane PLD and suggest
activity of both membrane-bound and partially purified PLD was asthat PIP, synthesis and hydrolysis could be important sayed utilizing C,-NBD-PC as a fluorescent substrate. The basic PLD
determinants in regulating PLD action in signal trans- reaction mixture (125 pl) contained 50 mM Na-Hepes, pH 7.2, and C,duction and membrane transport.
NBD-PC (0.3 mM). Membrane-bound PLD activity was determined by
measuring C,-NBD-phosphatidylpropanol (C,-NBD-PPr)production
(via trans-phosphatidylation)in the presence of 1-propanol(l%,v/v) as
Phosphatidylinositol 4,5-bisphosphate (PIP,)’ is a quantita- substrate, sodium oleate (0.45 mM, -50 mol %) as anactivator, and 12.5
pg of membrane protein. Partially purified PLD activity was detertivelyminor,highlyacidicphospholipid
that serves as a mined by measuring either C,-NBD-phosphatidic acid (C,-NBD-PA)or
C,-NBD-PPr production,in thepresence of Triton X-100 (1mM) and 2.5
* This research was supported in part by Grant GIF 1-165-078 from pg of partially purified PLD. PIP,, other activators, and neomycin were
the German-Israeli Foundation (to M. L.) and National Institutes of added to the reaction mixtures as indicated in the figures. Reactions
Health Grant GM 36624 (to L. C. C.). The costs of publication of this
were carried out for 10 min at 37 “C.Termination and TLC separation
article were defrayed in part by the payment of page charges. This of the products were performed essentially as described (10). The PLD
article must therefore be hereby marked “aduertisement”in accordance products were visualized on a UV transilluminator, and a video image
with 18 U.S.C. Section 1734 solelyto indicate this fact.
llIncumbent of the Shloimo and Mlchla Tomarincareer development was captured on a U W Gel Documentation System. The bands corresponding to C,-NBD-PA and/or C,-NBD-PPrwere scraped from the
chair in membrane physiology.
11 Supported by a fellowship from the Italian Association for Cancer plates and extracted with methanol. The fluorescence of the methanol
extracts was determined in a Hitachi F200 spectrofluorometer(excitaResearch.
The abbreviations used are: PIP,, phosphatidylinositol 4,5-bisphos- tion at 468 nm and emission at 520 nm). Unless otherwise indicated,
phate; ARF,ADP-ribosylation factor; C,-NBD-PC, l-palmitoyl-2-[6-N- PLD activity is expressed as the amount (in fluorescence units) of C,NBD-PA or C,-NBD-PPr produced in 10 min.
(7-nitrobenzo-2-oxa-1,3-diazol-4-yl~aminolcaproyl-phosphatidylcholine;
GAP, GTPase-activating protein; GTPyS, guanosine 5’-0-(3-thiotriphosphate); PA, phosphatidic acid; PC, phosphatidylcholine;PLD, phos- (P,y-imino)triphosphate; AMP-PCP, adenosine 5‘-O-(P,y-methylene)pholipase D; PPr, phosphatidylpropanol; AMP-PNP, adenosine 5’-0- triphosphate.
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FK:.2. Dependence of PLD activation on PIP, concentration.
The activity of a partially purified preparation of brain membrane PLD
was determined in the presenceof increasing PIP, concentrations.Following incubations lipids were extracted and separated by TLC. The
bands corresponding toC,;-NBD-PPr and C,-NBD-PA were quantitated
by spectrofluorometry. FU, fluorescence units.
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at a PIP, concentration of 6 mol %. At a higher concentration
(18 mol 8 )the stimulatoryeffect of PIP, was somewhat diminNone
PIP
PIP2
PI
PS
PA
ished.Essentiallyidenticalresultswereobtainedwiththe
standard system of Triton X-lOO/C,-NBD-PC (77:23, mol/mol)
Phospholipid
FIG.1. Effect of PIP, and other acidic phospholipids on brain (Fig. 3), indicatingthat the effect of PIP, is independent of the
membrane PLD activity. The activity of a partially purified prepara- physical nature of the micellar system. Fig. 3 also shows that
tion of brain membrane PLD was determined either in the absence of
phosphatidylinositol3,4,5-trisphosphate,whichisproduced
added lipid or in the presence of 10 p~ (0.76 mol 5 6 ) of the indicated
from PIP, bya phosphoinositide 3-kinase (4), can activate PLD
phospholipids. Following incubations, lipids were extracted and sepaas PIP, but with somewhat lower
rated by TLC, and fluorescent lipids were visualized
over a IJVlight and with about the same potency
efficacy. Since phosphatidylinositol 3,4,5-trisphosphate is more
photographed ( A ) . The bands corresponding to
C,-NBD-PPr and C,NBD-PA were scraped, extracted, and quantitated by spectrofluorom- negatively charged than PIP,, the results suggest that theacetry ( R ) .PIP, phosphatidylinositol 4-phosphate; PI, phosphatidylinosi- tivation of PLD by PIP, is not
a simple chargeeffect. Given that
tol; PS, phosphatidylserine; F.U., fluorescence units.
the levels of phosphatidylinositol 3,4,5-trisphosphate in memof its precursor,PIP,,
Protein Assay-Protein was determined using the modified Lowry branes are substantially lower than those
the possibility that PLD is activated by phosphatidylinositol
procedure of Markwell et al. (11).
3,4,5-trisphosphate, subsequent to activation of phosphoinosiRESULTS AND DISCUSSION
tide 3-kinase, seems unlikely.
Neomycin is a cationic aminoglycoside antibiotic t h a t exhibNeomycin (1 mM) inhibits the activity of the membraneits high binding affinity for inositol phospholipids but not for bound PLD (assayed in the presence
of sodium oleate, without
choline phospholipids (12-14). Yet, neomycin and related ami- exogenously added PIP,) by -75% (Fig. 4A). This result connoglycosides potently inhibit brain membranePC-specific PLD firms our previous observations obtained with
P3H1PC as a PLD
activity assayedin vitro in the presence
of a detergent activator substrate. However, as shown in Fig. 4, B and C, solubilization
(sodiumoleate) as well as G protein-mediatedactivation of and further purification of brain membrane PLD result in a
PLD in permeabilized NG108-15 cells (9). We have therefore nearly complete loss
of the inhibitoryeffect of neomycin on both
postulated that neomycin inhibits PLD activity by interaction
basal (Fig. 4B) and oleate-activated PLD activity (Fig. 4C).
with an essential membrane cofactor for PLD. The high affinity
This observation is consistent with our previous suggestion
of aminoglycosides for inositol lipids and, specifically, for PIP, t h a t neomycin does not interact with PLD directly(9).Rather,
raised the possibility that the postulated membrane cofactor it
is indicates that neomycin interacts with
a membrane cofactor
PIP,. This hypothesis was examined by testing the effects of that is essential for optimal PLD activity and
that has been
PIP, on the activity of a partially purified PLD in comparison removed during the purification process. The inhibitory effect
with other acidic phospholipids. PIP, dramatically stimulated of neomycin, lost upon the solubilization and purification
of
PLD activity, causing
a 6- and8-fold increase in PLD hydrolytic PLD, can be restoredif PLD activity is assayed in the presence
and trans-phosphatidylation activity, respectively (Fig. 1). In of PIP,. As shown in Fig. 4 0 , neomycin inhibits PIP,-stimucontrast, phosphatidylinositol 4-phosphate, phosphatidylinosi- lated PLD activity in a dose-dependent manner, causing 50%
tol, phosphatidylserine, and PA were completely or nearly ininhibition at a concentration (IC5o)of 90 PM, in verygood agreeeffective, indicating that the action of PIP, on PLD is highly
ment with its IC,, on PLD in membrane preparations (65 p ~ )
specific.
(9).This result indicates
that neomycin inhibits PLD activity in
The dependenceof PLD on PIP, concentration was examined membranes and permeabilized cells by binding to endogenous
in mixed micellar systems containing either
C,-NBD-PC/Triton
membrane PIP,.
X-100 (65:35, mol/mol)or TritonX-lOO/C,-NBD-PC (77:23, mol/
The present data demonstratethat exogenous PIP, is a spemol), with increasing concentrations of PIP,. Fig. 2 shows the cific and potent activatorof PLD. The specificity of PIP, action
resultsobtainedwith
C,-NBD-PC/Triton X-100 (65:35, mol/ is evinced by the ineffectiveness of other acidic phospholipids,
mol). The activity of PLD was stimulated by PIP, in a dose- including the closely related phosphatidylinositol and phosdependent manner, with a half-maximal effect at a concentra- phatidylinositol 4-phosphate. Furthermore, the action of PIP,
tion (EC,,) of 0.2-0.4 mol 5% and a maximal 10-fold stimulation is evident at physiological concentrations. Sulpice et al. (15)
I
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must be (i) membrane-associated;(ii) dissociable following
sohbilization with a non-ionic detergent; (iii) a high afflnity ligand
of neomycin; and (iv) required for optimal PLD activity. PIP,
satisfies these criteria. Further evidence that neomycin inhibits membrane-bound PLDby interaction with endogenous
membrane PIP, is provided by the fact that it inhibits with a
very similar potency the membrane-bound PLD and the purified PLD stimulated with exogenous PIP, (Ref. 9 and Fig. 4 0 ,
respectively).Moreover, the IC,, values for neomycininhibition
of PLD (65 and 90 p ~ are
) comparable with that obtained for
inhibition of PIP, hydrolysis by phosphoinositide-specificphos; 16) and are in excellent agreement
pholipase C (150 p ~ Ref.
with the binding affinity of neomycin to PIP, (11-46 p ~ Ref.
;
17). We conclude that PIP, acts as a cofactor that is required for
maximal PLD activity. It should be noted that, under in vitro
conditions, PIP, is not absolutely required for detecting PLD
activity (e.g. Fig. 4, B and C ) . Presumably the presence of
- , ..
0
1
1
io
detergents (Triton X-100, sodiumoleate) can substitute in part
Polyphosphoinosilide (mol%)
for the PIP, requirement. In addition, while PIP, would norFIG.3. Comparison of PLD activation by phosphatidylinositol mally act as a cofactor, it may also assume the role of a PLD
3,4,&trisphosphate and PIP,. The activity of a partially purified
preparation of brain membrane PLD wasdetermined in the presence of activator under specific conditions(see below).
The present results shed new light on the effect of MgATP on
increasing phosphatidylinositol 3,4,5-trisphosphate or PIP, concentrations. Following incubations, lipids were extracted and separated by PLD activation in cell-free systems. Although MgATP is not
TLC. The band correspondingto C,-NBD-PPr was quantitated by spec- absolutely required, it greatly potentiates the activation of PLD
trofluorometry. Results represent the mean * S.D. of two experiments by GTPyS in a variety of experimental systems (18-24). Sigcarried out in duplicate. F.U.,fluorescence units,
nificantly, the non-phosphorylating analogs of ATP, AMP-PNP
and AMP-PCP, are incapable of potentiating PLD activation,
suggesting that MgATP acts as a phosphoryl group donor in a
kinase-mediated phosphorylation reaction. The kinaseinvolved in MgATP action has not been identified. Protein kinase
C (21), tyrosine kinase(s) (23, 241, and a Ca2+-calmodulin-dependent kinase (22) were proposed as mediators of this effect.
The results presented herein raise the possibility that MgATP
potentiates PLD activation in permeabilized cells, because it is
required for the action of phosphoinositide kinases, i.e. phosphatidylinositol4-kinase and phosphatidylinositol 4-phosphate
5-kinase, in maintainingsufficient PIP, for optimal PLD activCon
Nea
Con
Nea
Con
NBO
0
10
1W
1000
[Neomycin] (cM)
ity. This possibility is consistent with the above evidence,indiFIG.4. Effect of neomycin on membrane-bound and partially cating that PIP, acts as a cofactor for brain membrane PLD,
purified PLD activity. PLD activity was determined in brain mem- and with our previous observation that neomycin inhibits
branes (A) and in a partially purified preparation of PLD assayed in the
absence of any activator (B),in thepresence of 0.7 m~ sodium oleate GTPyS-induced activation of PLD in permeabilized cells (9).It
(C), or in thepresence of 1mol % PIP, (D).
Neomycin was included in is also consistent with recent results showing that inclusion of
the assay at a concentration of 1m~ (A, B, and C ) or as indicated (D). PIP, in mixed PC/phosphatidylethanolamineliposomes greatly
Membrane-bound PLD activity (A) was determined by measuring for- potentiates the activation of granulocyte PLD by the small G
mation of C,-NBD-PPr in the presence of 1-propanol,and the partially
protein ADP-ribosylation factor (ARF)(25). Studies indicating
purified PLD activity was determined by measuring formation of C,NBD-PA. Results are expressed as the percentage of maximal PLD that on-going PIP, synthesis is indeed critical for PLD activaactivities which were (mean * S.D.): 142 10 (A), 74 t 5 ( B ) ,721 2 25 tion in permeabilized cells are currently in progress.'
(C), and 532 2 19 (D)
fluorescence unitdl0 min. The absence of an error
ARF is involved in multiple membrane transport processes,
bar indicates error smaller than symbol size.
where it promotes vesicle coat protein assembly and vesicle
budding from donor membranes (see Ref. 7 for review). The
have shown recently that theconcentration of PIP, in erythro- identification of ARF as an activator of PLD in myeloid cells
cyte membranes is -1% of total phospholipids. Assumingthat (25, 26) strongly implicates PLD and its biologically active
PIP, is asymmetrically distributed and is present predomi- product, PA, in vesicular trafficking. The function(s) of PLD
nantly in the inner leaflet of the membrane, the surface con- and PA in vesicular traffic are, however, currently unknown.
centration of PIP, in thatleaflet will approach 2 mol %. At this Intriguingly, evidence that polyphosphoinositide synthesis may
concentration the activation of PLD by PIP, was nearly maxi- be important for membrane transport events is also emerging
mal. Thus, the concentration-response relationship for activa- (27). A phosphatidylinositol transfer protein (the SECl4 gene
tion of PLD by PIP, is inexcellent agreement with the proposal product) is required for constitutive secretion in yeast (28,29),
that PIP, acts as a PLD cofactor.
as well as for neurotransmitter release in PC12 cells (30). AnThe fact that exogenous PIP, stimulates PLD activity does other yeast membrane traffic mutant, WS34,involved in pronot in itself prove that endogenous PIP, serves as acofactor for tein sortingto vacuoles, was identified recently as aphosphatiPLD. Evidence that this is indeed the case is provided by the dylinositol 3-kinase (31). In addition, phosphatidylinositol
experiments with neomycin. Whereas the activity of the mem- 4-kinase activity is localized in secretory granules from adrenal
brane-bound PLD is inhibited by neomycin, the solubilized and chromaffin cells(32, 33), in coated vesicles(34), and in glucose
partially purified enzyme is virtually insensitive to the aminoglycoside. This result shows that neomycin does not directly
P. Pertile, M. Liscovitch,V. Chalifa, and L. C.Cantley, manuscript in
interact with PLD but, rather, with a cofactor. The cofactor preparation.
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The present study defines a novel function of PIP, as a cofactor for brain membrane PLD. The requirement of PIP, for
maximal PLD activity suggests thatPIP, synthesis and breakdown may regulate PLD activation. Possible physiological functions inwhich this interaction islikely t o be critical are delineated, anda testable hypothetical model for its role in vesicular
traffic is proposed. Further studies aimed at the characterization and kinetic analysis of the interaction between PIP, and
PLD and the role of PIP, biosynthesis in PLD activation and
membrane transport are currently inprogress.

P14K

Coated vesicle

FIG.5. Positive feedback between PLD activation and PIPz
biosynthesis in ARF-regulated vesicular fusion: a hypothetical
model. See text for details. PI4K, phosphatidylinositol 4-kinase; PIP,
phosphatidylinositol 4-phosphate; PIP5K, phosphatidylinositol 4-phosphate 5-kinase.

transporter-carrying (GLUT 4) vesicles (35).Thus, the activation of PLD by ARF and the biosynthesis of PIP, may act in
concert in a general mechanism for membrane vesiculation
and/or fusion. This view is supportedby recent studiesshowing
that PA can dramatically stimulate the activity of the type I
phosphatidylinositol4-phosphate5-kinase,
a n enzyme that
produces PIP, (36, 37).
The ability of PIP, to activate PLD and the ability of PA to
activate phosphatidylinositol 4-phosphate 5-kinase suggest a
model in which the formation ofPA and PIP,, by PLD and
phosphatidylinositol 4-phosphate 5-kinase, respectively, participates ina positive feedback loop that may playa n important
role in vesicle fusion with acceptor membranes (Fig. 5). According to this model, the GTP-bound form of ARF induces the
assembly of coated vesicles on donor membranes and their
budding off (38). Transport vesicles are likely to be enriched
with phosphatidylinositol4-phosphatebecause
theycarry
phosphatidylinositol 4-kinase activity (32-35). The interaction
of coated vesicles bearing ARF.GTP with acceptor membranes
will activate PLD associated with these membranes,producing
PA (25, 26). The activity of phosphatidylinositol 4-phosphate
5-kinase, which is hypothesized t o be located at acceptor membranes, will be stimulated by PA resulting inmassive synthesis
of PIP, from vesicular phosphatidylinositol 4-phosphate. This,
in turn, will cause further stimulationof PLD activity. Such a
positive feedback loop will effect a very rapid and profound
change in the lipid composition of the vesicular membranes,
leading to theformation of microdomains that are depleted of
PC and phosphatidylinositol and are greatly enriched in PA
and PIP,. A positive feedback loop such as the one proposed
here must be controlled tightly by shut-off mechanisms. ARF
GTPase-activating protein (ARF GAP) is likely to subserve this
function. The activity of ARF GAP is stimulated dramatically
and synergistically by PIP, and PA(39). Thus, the interaction
of
ARF GAP with the PIPPA-richvesicle membranes will cause
its activation, stimulationof the GTPase activity of ARF, and
the conversion of active ARF.GTP to inactive ARF.GDP. This
will shut off PLD activity, thus halting the positive feedback
loop, and initiate thedisassembly of the coated vesicle (401, allowing its subsequent fusion with acceptor membranes. According to this model ARF plays a role in initiating bothvesicle budding and vesicle fusion. Indeed, an ARF N-terminal
peptide inhibits catecholamine release in adrenal chromaffin
cells (41),and several linesof evidence suggest thatPLD activation is involved in exocytosis (reviewed in Ref. 6 ) . The fusion of vesicles that are enriched with the negatively charged
phospholipids PIP, and PA is likely to be greatlyfacilitated by
Ca" ions (42).
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